KIOM-4 Protects against Oxidative Stress-Induced Mitochondrial Damage in Pancreatic β-cells via Its Antioxidant

Kyoung Ah Kang1, Jin Sook Kim, Rui Zhang

  • 1School of Medicine, Jeju National University, Jeju-si 690-756, Republic of Korea.

Insights

KIOM-4, a plant extract mixture, protects pancreatic beta cells from diabetes-induced mitochondrial damage. It reduces oxidative stress and improves mitochondrial function, offering a potential therapeutic approach for diabetes.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Streptozotocin (STZ) induces mitochondrial oxidative stress in pancreatic beta cells, contributing to diabetes.
  • Oxidative stress damages cellular components, leading to mitochondrial dysfunction and cell death.

Purpose of the Study:

  • To investigate the protective effects of KIOM-4 against STZ-induced mitochondrial damage in rat pancreatic beta cells (RINm5F).
  • To elucidate the underlying mechanisms of KIOM-4's protective action, focusing on antioxidant and mitochondrial protective properties.

Main Methods:

  • In vitro antioxidant assays to assess radical scavenging activity of KIOM-4.
  • STZ-induced diabetic cell model (RINm5F) to evaluate KIOM-4's effects on mitochondrial ROS, Mn SOD, Nrf2, lipid peroxidation, DNA damage, and mitochondrial membrane potential.
  • Assessment of cytochrome c translocation, ATP levels, succinate dehydrogenase activity, and insulin secretion.

Main Results:

  • KIOM-4 demonstrated significant scavenging activity against superoxide and hydroxyl radicals.
  • KIOM-4 treatment attenuated STZ-induced increases in mitochondrial ROS, lipid peroxidation, protein carbonyls, and DNA modification.
  • KIOM-4 upregulated mitochondrial manganese superoxide dismutase (Mn SOD) activity and protein expression, partly via Nrf2 activation.
  • KIOM-4 restored mitochondrial membrane potential, inhibited cytochrome c release, and improved ATP production and succinate dehydrogenase activity.
  • KIOM-4 treatment normalized STZ-induced reduction in insulin levels.

Conclusions:

  • KIOM-4 exerts protective effects against STZ-induced mitochondrial oxidative stress and dysfunction in pancreatic beta cells.
  • The protective mechanisms involve potent antioxidant activity and direct preservation of mitochondrial integrity and function.
  • KIOM-4 represents a promising therapeutic agent for managing diabetes by mitigating beta cell damage.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
Electron Transport Chain: Complex III and IV01:43

Electron Transport Chain: Complex III and IV

During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...